Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
PaperCitations, authors & open-access status
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 846 citations, 2021 year and hybrid oa status.
846
Citations
2021
Year
hybrid
OA Status